Follow The Filings

TEAM Atlassian

Information Technology, filed as ATLASSIAN CORPORATION (CL A), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Sold by 3 managers in 2026 Q2

  • 2 Owners
  • Max 3.2%
  • $150M
  • 2 reduce 1 exit

In 2026 Q2 Grant Wonders and George Soros trimmed Atlassian, and Ron Baron sold out.

Who owns this now

Largest portfolio weights among holders, up to 3.2% (Grant Wonders, Voyager Global Management). Not free-float ownership.

  1. Grant Wonders Reduce 3.2%
  2. George Soros Reduce 0.44%

Who owns TEAM

Sorted by value, long equity only, as of 2026 Q2.

History
Grant Wonders, Voyager Global Management 3.2%, was 8.9% Reduce −61.8% 1,470,000 $114M History
George Soros, Soros Fund Management 0.44% Reduce −14.3% 459,150 $36M History
Ron Baron, Bamco Inc. (Baron Capital) exited 2026 Q2 Last 2026 Q1 <0.01% Exit 0.00% 1,845 $126K History

2 current, 1 exited last period, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by TEAM's executives, directors and 10% owners in the last 12 months, from their Form 4s

All TEAM insider trades
  • $498K bought by 1 insider
  • None no sales outside a trading plan
  • $156M sold by 5 insiders under 10b5-1 plans
  1. Gene Liu Chief Accounting Officer
    Planned sale
    $71K 337 shares at $210.00 0.6% of stake
    Traded Oct 12 Filed Oct 13
    ↗
  2. Gene Liu Chief Accounting Officer
    Planned sale
    $178K 939 shares at $190.00 1.7% of stake
    Traded Aug 28 Filed Aug 31
    ↗
  3. Gene Liu Chief Accounting Officer
    Planned sale
    $197K 1,125 shares at $175.00 1.9% of stake
    Traded Aug 19 Filed Aug 20
    ↗
  4. Gene Liu Chief Accounting Officer
    Planned sale
    $122K 737 shares at $165.00 1.2% of stake
    Traded Aug 13 Filed Aug 17
    ↗
  5. Brian Duffy Chief Revenue Officer
    Planned sale
    $565K 6,245 shares at $90.39 2.7% of stake
    Traded Jun 10–12 Filed Jun 12
    ↗
  6. Brian Duffy Chief Revenue Officer
    Planned sale
    $281K 2,905 shares at $96.69 1.2% of stake
    Traded Jun 8–9 Filed Jun 9
    ↗
  7. Scott Farquhar Director
    Planned sale
    $727K 7,665 shares at $94.81 2.7% of stake
    Traded Feb 6 Filed Feb 6
    ↗
  8. Scott Farquhar Director
    Planned sale
    $784K 7,665 shares at $102.28 2.6% of stake
    Traded Feb 5 Filed Feb 6
    ↗
  9. Michael Cannon-Brookes CEO
    Planned sale
    $784K 7,665 shares at $102.28 2.6% of stake
    Traded Feb 5 Filed Feb 6
    ↗
  10. Scott Farquhar Director
    Planned sale
    $806K 7,665 shares at $105.14 2.6% of stake
    Traded Feb 4 Filed Feb 5
    ↗
  11. Michael Cannon-Brookes CEO
    Planned sale
    $806K 7,665 shares at $105.14 2.6% of stake
    Traded Feb 4 Filed Feb 5
    ↗
  12. Scott Farquhar Director
    Planned sale
    $797K 7,665 shares at $104.04 2.5% of stake
    Traded Feb 3 Filed Feb 4
    ↗
  13. Michael Cannon-Brookes CEO
    Planned sale
    $797K 7,665 shares at $104.04 2.5% of stake
    Traded Feb 3 Filed Feb 4
    ↗
  14. Scott Farquhar Director
    Planned sale
    $892K 7,665 shares at $116.40 2.4% of stake
    Traded Feb 2 Filed Feb 3
    ↗

Also filed in the last 12 months, not counted as buying or selling: 164 sales to cover taxes, 15 stock grants, and 2 conversions.

Congress

1 member of Congress traded TEAM in the last three years: 3 buys and 2 sales. 2 members listed it in 2025 annual reports.

All Congress trades
  1. Robert P. Bresnahan, Jr. R-PA-8 Sell $1K–$15K Jun 11, 2025 filed Jul 8, 2025
  2. Robert P. Bresnahan, Jr. R-PA-8 Partial sale $1K–$15K Jun 3, 2025 filed Jul 8, 2025
  3. Robert P. Bresnahan, Jr. R-PA-8 Buy $1K–$15K Jan 28, 2025 filed Feb 13, 2025
  4. Robert P. Bresnahan, Jr. R-PA-8 Buy $1K–$15K Jan 28, 2025 filed Feb 13, 2025
  5. Robert P. Bresnahan, Jr. R-PA-8 Buy $1K–$15K Jan 28, 2025 filed Feb 13, 2025

SEC filings

Recent issuer filings from EDGAR, 18 shown.

Filed Form Detail Links
DEF 14A Filing Doc
DEFA14A Filing Doc
10-K Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,8.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.05,5.02,7.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 12 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025 FY2026
Revenue $3.53B $4.36B $5.22B $6.57B
Gross profit $2.9B $3.56B $4.32B $5.58B
Gross margin * 82.1% 81.6% 82.8% 84.8%
Net income -$486.76M -$300.52M -$256.69M -$53.83M
Net margin * -13.8% -6.9% -4.9% -0.8%

Balance sheet

Metric FY2023 FY2024 FY2025 FY2026
Total current assets $2.74B $3.08B $3.89B $2.8B
Total non-current assets * $1.37B $2.14B $2.15B $3.31B
Total assets $4.11B $5.21B $6.04B $6.1B
Total current liabilities $2.03B $2.61B $3.18B $3.57B
Total non-current liabilities * $1.42B $1.57B $1.52B $1.47B
Total equity $0.655B $1.03B $1.35B $1.06B

Cash flow

Metric FY2023 FY2024 FY2025 FY2026
Cash from operations $0.868B $1.45B $1.46B $1.35B
Cash from investing -$1.26M -$963.75M -$342.32M -$806.89M
Cash from financing -$0.148B -$0.408B -$0.783B -$1.8B
Net change in cash $0.717B $0.074B $0.336B -$1.26B

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.